CLASS II Device recall · Reported 30 Jun 2021 · FDA Enforcement Report

reSET Mobile App, iOS and Android recalled by Pear Therapeutics

Pear Therapeutics is recalling reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of, distributed in 16 states. The recall was initiated on 7 Jun 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI Codes: reSET Mobile App, iOS (01) 10851580008088 (10) 1 reSET Mobile App, Android (01) 10851580008095 (10) 1
Quantity recalled812 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1925-2021
FDA event ID
88061
Recalling firm
Pear Therapeutics, San Francisco, CA
Classification
Class II
Status
Terminated
Recall initiated
7 Jun 2021
FDA classified
21 Jun 2021
Reported
30 Jun 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

7 Jun 2021Recall initiated by company
21 Jun 2021Classified by FDA+14 days
30 Jun 2021Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positive UDS results should not have resulted in access to a wheel spin.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of substance abuse treatment.

Where it was distributed

U.S.: AZ, CA, DE, FL, IL, IN, KY, MA, MD, MN, NC, NY, OH, TN, WA, and WI O.U.S.: N/A

ArizonaCaliforniaDelawareFloridaIllinoisIndianaKentuckyMassachusettsMarylandMinnesotaNorth CarolinaNew YorkOhioTennesseeWashingtonWisconsin

Questions about this recall

Is reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of recalled?

Yes. Pear Therapeutics recalled reSET Mobile App, iOS and Android, provides cognitive behavioral therapy, as part of on 7 Jun 2021. The recall is Class II and its status is Terminated. Recall number Z-1925-2021.

Why was it recalled?

Due to a software issue, patients with a urine drug screen (UDS) received access to a contingency management wheel spin for potential rewards regardless of the UDS results. Positive UDS results should not have resulted in access to a wheel spin.

Which lots are affected?

UDI Codes: reSET Mobile App, iOS (01) 10851580008088 (10) 1 reSET Mobile App, Android (01) 10851580008095 (10) 1

Where was it sold?

U.S.: AZ, CA, DE, FL, IL, IN, KY, MA, MD, MN, NC, NY, OH, TN, WA, and WI O.U.S.: N/A

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pear Therapeutics

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIreSET-O Mobile App, iOS and Android recalled by Pear TherapeuticsPear TherapeuticsDevice Malfunction16 states

Other Medical Software recalls

All 903